Montana § 50-32-230 Board Authorized To Exempt Certain Compounds, Mixtures, Or Preparations From Schedule Iv

Montana Statutes

§ 50-32-230 — Board Authorized To Exempt Certain Compounds, Mixtures, Or Preparations From Schedule Iv

Montana § 50-32-230

Title 50HEALTH AND SAFETY

Ch. 32CONTROLLED SUBSTANCES

Part 2Scheduling of Dangerous Drugs

This text of Montana § 50-32-230 (Board Authorized To Exempt Certain Compounds, Mixtures, Or Preparations From Schedule Iv) is published on Counsel Stack Legal Research, covering Montana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Mont. Code Ann. § 50-32-230 (2026).

Text

50-32-230 . Board authorized to exempt certain compounds, mixtures, or preparations from Schedule IV. The board may except by rule any compound, mixture, or preparation containing any depressant drug listed in 50-32-229 from the application of all or any part of this chapter if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the drugs which have a depressant effect on the central nervous system.

Free access — add to your briefcase to read the full text and ask questions with AI

50-32-230 . Board authorized to exempt certain compounds, mixtures, or preparations from Schedule IV. The board may except by rule any compound, mixture, or preparation containing any depressant drug listed in 50-32-229 from the application of all or any part of this chapter if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the drugs which have a depressant effect on the central nervous system.